Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Early treatment with JAK inhibitors leads to better hair regrowth in acute alopecia areata.

Topical tofacitinib is effective and safe for treating alopecia areata.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Targeting PTEN can improve healing in venous leg ulcers.

Avacopan may cause unexpected side effects, so early monitoring is important.

The water extract of Bituminaria bituminosa, high in phenolic compounds, shows strong antioxidant and enzyme inhibitory potential.

Urtica laetevirens extract significantly reduces 5α-reductase activity.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

The "simmer pus and grow flesh" method helps heal chronic wounds in rats.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Baricitinib is the most effective treatment for alopecia areata.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.